Seite - (000268) - in Biomedical Chemistry: Current Trends and Developments

Morris, M. C.; Vidal, P.; Chaloin, L.; Heitz, F.; Divita, G. A (1997). New peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Research 25, 2730-2736.. Mulholland, P. J.; Ferry, D. R.; Anderson, D.; Hussain, S. A.; Young, A. M.; Cook, J. E.; Hodgkin, E.; Seymour, L. W.; Kerr, D. J. (2001). Pre-clinical and clinical study of QC12, a water-soluble, prodrug of quercetin, Annals of Oncology, 12, 245-248. Myrberg, H.; Zhang, L.; Mäe, M.; Langel, Ü. (2008). Design of a tumor-homing cell-penetrating peptide. Bioconjugate Chemistry, 19, 70-75. Nam, N. H.; Kim, Y.; You, Y. J.; Hong, D. H.; Kim, H. M.; Ahn, B. Z. (2003). Water soluble prodrugs of the antitumor agent 3-[(3-amino-4-methoxy)phenyl]-2-(3,4,5-trimethoxyphenyl) cyclopent- 2-ene-1- one. Bioorganic and Medicinal Chemistry, 11, 1021-1029. Nakanishi, T.; Tamai, I.; Takaki, A.; Tsuji, A. (2000). Cancer cell targeted drug delivery utilizing oligopeptide transport activity. International Journal of Cancer, 88, 274-280. Northfield, S. E:; Wang, C. K.; Schroeder, C. I.; Durek, T.; Kan, M. W.; Swedberg, J. E.; Craik, D. J. (2014). Dissulfide-rich macrocyclic peptides as templates in drug design. European Journal Medicinal Chemistry, 77, 248-257. Oehlke, J.; Scheller, A.; Wiesner, B.; Krause, E.; Beyermann, M.; Klauschenz, E.; Melzig, M.; Bienert, M. (1998). Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochimica et Biophysica Acta, Biomembranes, 1414, 127-139. O’Leary, L. E.; Fallas, J. A.; Bakota, E. L.; Kang, M. K.; Hartgerink, J. D. (2011). Multi-hierarchical self-assembly of a collagen mimetic peptide from triple helix to nanofibre and hydrogel. Nature Chemistry, 3, 821-828. Orbach, R.; Adler-Abramovich, L.; Zigerson, S.; Mironi-Harpaz, I.; Seliktar, D.; Gazit, E. (2009). Self-assembled fmoc-peptides as a platform for the formation of nanostructures and hydrogels. Biomacromolecules, 10, 2646-2651. Oskolkov, N.; Arukuusk, P.; Copolovici, D. M.; Lindberg, S.; Margus, H.; Padari, K.; Pooga, M.; Langel, Ü. (2011). Nickects, phosphorylated derivatives of transportan 10 for cellular delivery of oligonucleotides. International Journal of Peptide Research and Therapeutics, 17, 147-157. Page-McCaw, A.; Ewald, A. J.; Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nature Reviews. Molecular Cell Biology, 8, 221-233. Pardridge, W. M. (2003). Blood-brain barrier drug targeting: the future of brain drug development. Molecular Interventions, 3, 90-105. Park, C. B.; Kim, H. S.; Kim, S. C. (1998). Mechanism of action of the antimicrobial peptide buforin ii: Buforin ii kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochemical and Biophysical Research Communications, 244, 253-257. Patrzykat, A.; Friedrich, C. L.; Zhang, L.; Mendoza, V.; Hancock, R. E. (2002). Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrobial Agents Chemotherapy, 46, 605-614. Pettit, D. K.; Gombotz, W. R. (1998). The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals. Trends in Biotechnology, 16, 343-349. Patterson, J.; Hubbell, J. A. (2011). SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials, 32, 1301-1310. Perta-Kajan, J.; Twardowski, T.; Jakubowski, H. (2007). Mechanisms of homocysteine toxicity in humans. Amino Acids, 32, 561-572.